Cart
sales@molnova.com
Dolutegravir intermediate-1
CAS No. 1335210-23-5
Dolutegravir intermediate-1( 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1-(2,2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid )
Catalog No. M23489 CAS No. 1335210-23-5
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 52 | In Stock |
|
| 1G | 67 | In Stock |
|
Biological Information
-
Product NameDolutegravir intermediate-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionDolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
-
DescriptionDolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
-
In Vitro——
-
In Vivo——
-
Synonyms1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1-(2,2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1335210-23-5
-
Formula Weight314.27
-
Molecular FormulaC13H16NO8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (285.46 mM; Need ultrasonic)
-
SMILESCOC(CN(C=C(C([O-])=O)C1=O)C(C(OC)=O)=C1OC)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.
molnova catalog
related products
-
BMS-986001
A thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV-2 isolates from treatment-naive individuals with EC50 of 30-81 nM.
-
Peptide T
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and inhibiting cytokine action.
-
Des(benzylpyridyl) A...
Atazanavir is an highly potent HIV-1 protease inhibitor.
